Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Numao

Showing results (371-380 of 419) with videos related to

Pageof 42
Sort By:
Clinical Genitourinary Cancer|September 21, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA StudyHiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, et al.
Acta Neurologica Scandinavica|November 18, 2014
Evaluation of cutoff scores for the Parkinson's disease sleep scale-2K Suzuki, T Miyamoto, M Miyamoto, et al.
Stroke|May 7, 2021
Fluid-Attenuated Inversion Recovery May Serve As a Tissue Clock in Patients Treated With Endovascular ThrombectomyJunya Aoki, Yuki Sakamoto, Kentaro Suzuki, et al.
Cells|April 11, 2025
Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal DystrophySohya Fujimoto, Mako Endo, Shigehito Tonomura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2024
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastasesSoichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, et al.
Endocrine Journal|June 28, 2021
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinomaAkihiro Ohmoto, Yasuyuki Shigematsu, Naoki Fukuda, et al.
International Urology and Nephrology|September 12, 2013
Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancerHyeyeol Bae, Soichiro Yoshida, Yoh Matsuoka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2026
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)Rie Muta, Hiroshi Fukushima, Hajime Tanaka, et al.
Scientific Reports|April 21, 2022
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, JapanMasashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, et al.
Clinical Genitourinary Cancer|August 18, 2020
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature ReviewToshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, et al.
Pageof 42

Showing results (371-380 of 419) with videos related to

Sort By:
Pageof 42
Clinical Genitourinary Cancer|September 21, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA StudyHiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, et al.
Acta Neurologica Scandinavica|November 18, 2014
Evaluation of cutoff scores for the Parkinson's disease sleep scale-2K Suzuki, T Miyamoto, M Miyamoto, et al.
Stroke|May 7, 2021
Fluid-Attenuated Inversion Recovery May Serve As a Tissue Clock in Patients Treated With Endovascular ThrombectomyJunya Aoki, Yuki Sakamoto, Kentaro Suzuki, et al.
Cells|April 11, 2025
Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal DystrophySohya Fujimoto, Mako Endo, Shigehito Tonomura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2024
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastasesSoichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, et al.
Endocrine Journal|June 28, 2021
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinomaAkihiro Ohmoto, Yasuyuki Shigematsu, Naoki Fukuda, et al.
International Urology and Nephrology|September 12, 2013
Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancerHyeyeol Bae, Soichiro Yoshida, Yoh Matsuoka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2026
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)Rie Muta, Hiroshi Fukushima, Hajime Tanaka, et al.
Scientific Reports|April 21, 2022
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, JapanMasashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, et al.
Clinical Genitourinary Cancer|August 18, 2020
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature ReviewToshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, et al.
Pageof 42